Comparative tolerability of systemic treatments for plaque-type psoriasis. Introduction: Several studies have shown the efficacy of cyclosporine in the treatment of chronic plaque-type psoriasis. Aim: The aim of this retrospective study was to assess the clinical response and toxicity of cyclosporine in a small cohort of patients with refractory plaque-type psoriasis. Hamilton TA, Parish TG (1991) Cyclosporine for plaque-type psoriasis.
Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 1991;324(5): 27784. Reitamo S, Spuls P, Sassolas B, et al. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. Cyclosporine improves psoriasis in a double-blind study. JAMA.
Methods: In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate. Methotrexate and Cyclosporine in Psoriasis Revisited. Cyclosporine; methotrexate; psoriasis treatment;TNF. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
Psoriasis: Advances In Knowledge And Care, An Issue Of Dermatologic Clinics
Intralesional cyclosporine versus dithranol in the treatment of plaque-type psoriasis. Background: Chronic plaque psoriasis is frequently associated with obesity. Objective: The objective was to investigate whether moderate weight loss (ie, 5 10 of body weight) increases the therapeutic response to a low dose of cyclosporine in obese patients with moderate-to-severe chronic plaque psoriasis. Collected data included age, sex, weight, height, BMI, age of psoriasis onset, type and severity of psoriasis, and concomitant medications. Learn about the potential side effects of cyclosporine. Messana JM, et al Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial. Cyclosporine forplaque-type psoriasis: resultsofa multidose, double-blind trial.